Predicting Survival in Patients with Metastatic Kidney Cancer by Gene-Expression Profiling in the Primary Tumor
To identify potential molecular determinants of tumor biology and possible clinical outcomes, global gene-expression patterns were analyzed in the primary tumors of patients with metastatic renal cell cancer by using cDNA microarrays. We used grossly dissected tumor masses that included tumor, blood...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 100; no. 12; pp. 6958 - 6963 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
10.06.2003
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To identify potential molecular determinants of tumor biology and possible clinical outcomes, global gene-expression patterns were analyzed in the primary tumors of patients with metastatic renal cell cancer by using cDNA microarrays. We used grossly dissected tumor masses that included tumor, blood vessels, connective tissue, and infiltrating immune cells to obtain a gene-expression "profile" from each primary tumor. Two patterns of gene expression were found within this uniformly staged patient population, which correlated with a significant difference in overall survival between the two patient groups. Subsets of genes most significantly associated with survival were defined, and vascular cell adhesion molecule-1 (VCAM-1) was the gene most predictive for survival. Therefore, despite the complex biological nature of metastatic cancer, basic clinical behavior as defined by survival may be determined by the gene-expression patterns expressed within the compilation of primary gross tumor cells. We conclude that survival in patients with metastatic renal cell cancer can be correlated with the expression of various genes based solely on the expression profile in the primary kidney tumor. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Abbreviations: RCC, renal cell cancer; VCAM, vascular cell adhesion molecule. Contributed by Richard D. Klausner, March 26, 2003 To whom correspondence should be addressed at: Urologic Oncology Branch, Center for Cancer Research, Building 10, Room 2B47, National Cancer Institute, Bethesda, MD 20892-1501. E-mail: uob@mail.nih.gov. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1131754100 |